[ad_1]
It also notes that about 65% of people in the highest risk group, aged 65 and over, have already acquired at least partial immunity. people, increased immunization of this group is very important to prevent deaths. We see a particularly rapid decline in new cases in the Vilnius region, where the number of cases has dropped by 40%. from a peak two weeks ago.
Hospitalization in the Vilnius region has also entered a phase of decline, but an increase is still visible in the Šiauliai region. The vaccination rate has not changed and most of the first doses of the vaccine are now given to people ages 45 to 65.
Aistis Šimaitis, the government’s project manager, who prepared the review, notes that in Lithuania, at least 38 percent of COVID-19 are likely to be immune. population. This number is likely higher due to unidentified infections and people who had relapsed COVID-19 more than 6 months ago but still have immunity. 65 m. and older, this percentage exceeds 65 percent.
A.Šimaitis points out that since April 1 of this year. 86 percent. of all COVID-19 deaths were not vaccinated, another 6 percent. the deaths occurred in people who were infected with COVID-19 less than 4 weeks after the first vaccine, resulting in more than 90 percent. the deaths consisted of people who probably did not have immunity to the virus.
The age structure of the dead remains virtually unchanged at 80%. deaths are among the deaths of people in the age group 65 and over, so immunizing these people remains one of the key factors in reducing the number of deaths from the virus.
In Lithuania, the peak of the third wave is already visible in most indicators: the number of 7-day cases, the percentage of positive tests, the 14-day morbidity and the negative acceleration.
The review also notes that regional disparities persist. In the Vilnius region, we are seeing a two-week decrease in the number of cases and a one-week decrease in hospital employment. In the Šiauliai region, growth in the number of cases has stabilized, but hospital employment continues to increase.
The vaccination rate and the structure of those vaccinated remain unreliable. About half of vaccines are made up of second doses, and most of those who receive the first dose are between 45 and 54 years old and between 55 and 64 years old.
